phenylacetic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4624 103-82-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • benzeneacetic acid
  • phenylacetic acid
  • phenylethanoic acid
  • sodium phenylacetate
  • Molecular weight: 136.15
  • Formula: C8H8O2
  • CLOGP: 1.41
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 1
  • TPSA: 37.30
  • ALOGS: -1.58
  • ROTB: 2

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Dec. 23, 1987 FDA B BRAUN

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A16AX30 ALIMENTARY TRACT AND METABOLISM
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Various alimentary tract and metabolism products
MeSH PA D000963 Antimetabolites
MeSH PA D000964 Antimetabolites, Antineoplastic
MeSH PA D000970 Antineoplastic Agents
MeSH PA D009676 Noxae
FDA MoA N0000175806 Ammonium Ion Binding Activity
FDA EPC N0000175807 Nitrogen Binding Agent
CHEBI has role CHEBI:22676 auxins
CHEBI has role CHEBI:27026 toxins
CHEBI has role CHEBI:35219 plant growth inhibitors
CHEBI has role CHEBI:50904 alergeno
CHEBI has role CHEBI:75772 S. cerevisiae metabolites
CHEBI has role CHEBI:76924 plant metabolites
CHEBI has role CHEBI:76956 Aspergillus metabolites
CHEBI has role CHEBI:76971 Escherichia coli metabolites
CHEBI has role CHEBI:77746 Homo sapiens metabolite
CHEBI has role CHEBI:90318 EC 6.4.1.1 (pyruvate carboxylase) inhibitors

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hyperammonemia indication 9360008
Hypokalemia contraindication 43339004
Body fluid retention contraindication 43498006
Chronic heart failure contraindication 48447003
Acute nephropathy contraindication 58574008
Metabolic acidosis contraindication 59455009
Hyperglycemia contraindication 80394007 DOID:4195
Kidney disease contraindication 90708001 DOID:557
Seizure disorder contraindication 128613002
Disease of liver contraindication 235856003 DOID:409
Edema contraindication 267038008
CNS Toxicity contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 4.37 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Aldose reductase Enzyme IC50 4.02 CHEMBL

External reference:

IDSource
D05867 KEGG_DRUG
114-70-5 SECONDARY_CAS_RN
4019576 VANDF
CHEBI:30745 CHEBI
PAC PDB_CHEM_ID
CHEMBL1044 ChEMBL_ID
CHEMBL1200358 ChEMBL_ID
C025136 MESH_SUPPLEMENTAL_RECORD_UI
DB09269 DRUGBANK_ID
ER5I1W795A UNII
999 PUBCHEM_CID
33332 RXNORM
19292 MMSL
d05460 MMSL
001244 NDDF
004954 NDDF
125705007 SNOMEDCT_US
398818001 SNOMEDCT_US
C0070620 UMLSCUI

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Ammonul HUMAN PRESCRIPTION DRUG LABEL 2 0187-0010 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS NDA 26 sections
SODIUM PHENYLACETATE and SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 13811-705 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 28 sections
Ammonul HUMAN PRESCRIPTION DRUG LABEL 2 62592-720 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS NDA 28 sections
Sodium Phenylacetate and Sodium Benzoate HUMAN PRESCRIPTION DRUG LABEL 2 67457-844 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 27 sections
SODIUM PHENYLACETATE AND SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 68382-396 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 24 sections
Sodium Phenylacetate and sodium benzoate HUMAN PRESCRIPTION DRUG LABEL 2 68475-001 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 24 sections
SODIUM PHENYLACETATE AND SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 68682-001 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS NDA authorized generic 26 sections
SODIUM PHENYLACETATE and SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 69784-810 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 28 sections
SODIUM PHENYLACETATE and SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 69784-811 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 28 sections
SODIUM PHENYLACETATE AND SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 70511-101 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 28 sections
Sodium Phenylacetate and Sodium Benzoate HUMAN PRESCRIPTION DRUG LABEL 2 70511-102 INJECTION 100 mg INTRAVENOUS NDA 29 sections
SODIUM PHENYLACETATE and SODIUM BENZOATE HUMAN PRESCRIPTION DRUG LABEL 2 70556-100 INJECTION, SOLUTION, CONCENTRATE 100 mg INTRAVENOUS ANDA 28 sections
Sodium Phenylacetate and Sodium Benzoate HUMAN PRESCRIPTION DRUG LABEL 2 72266-236 INJECTION 100 mg INTRAVENOUS NDA 29 sections